These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12101751)

  • 1. [Causative agents for lung carcinogenesis].
    Hanibuchi M; Sone S
    Nihon Rinsho; 2002 May; 60 Suppl 5():63-6. PubMed ID: 12101751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Causative agents for lung carcinogenesis].
    Yano S; Sone S
    Nihon Rinsho; 2000 May; 58(5):1017-22. PubMed ID: 10824542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
    Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EBM and molecular biology from the perspective of lung cancer due to tobacco smoking].
    Nakanishi Y; Takayama K
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1089-95. PubMed ID: 12866459
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure.
    Wang X; Christiani DC; Wiencke JK; Fischbein M; Xu X; Cheng TJ; Mark E; Wain JC; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):543-8. PubMed ID: 7549812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
    Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and ras gene mutations in lung cancer: implications for smoking and occupational exposures.
    Husgafvel-Pursiainen K; Ridanpää M; Anttila S; Vainio H
    J Occup Environ Med; 1995 Jan; 37(1):69-76. PubMed ID: 7620945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why is lung cancer common in non-smoking women in Hong Kong: from epidemiologic to molecular studies.
    Kit LW
    Chin Med J (Engl); 1997 Jun; 110(6):420-4. PubMed ID: 9594241
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland.
    Rusin M; Butkiewicz D; Malusecka E; Zborek A; Harasim J; Czyzewski K; Bennett WP; Shields PG; Weston A; Welsh JA; Krzyzowska-Gruca S; Chorazy M; Harris CC
    Br J Cancer; 1999 Jul; 80(9):1445-52. PubMed ID: 10424749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung cancer and idiopathic pulmonary fibrosis].
    Kudoh S; Yoshimura A
    Nihon Rinsho; 2002 May; 60 Suppl 5():716-9. PubMed ID: 12101770
    [No Abstract]   [Full Text] [Related]  

  • 15. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
    Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological trends in lung cancer in Japan].
    Hara N; Takano K; Inoshima N
    Nihon Rinsho; 2002 May; 60 Suppl 5():29-34. PubMed ID: 12101674
    [No Abstract]   [Full Text] [Related]  

  • 17. [Why does smoking cause lung cancer?].
    Nakanishi Y
    Fukuoka Igaku Zasshi; 2002 Jan; 93(1):6-10. PubMed ID: 11889829
    [No Abstract]   [Full Text] [Related]  

  • 18. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos.
    Kannio A; Ridanpää M; Koskinen H; Partanen T; Anttila S; Collan Y; Hietanen E; Vainio H; Husgafvel-Pursiainen K
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):33-9. PubMed ID: 8770464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
    Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
    Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
    Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.